Viewing Study NCT04617756


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-02-02 @ 12:45 AM
Study NCT ID: NCT04617756
Status: RECRUITING
Last Update Posted: 2023-05-30
First Post: 2020-10-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
Sponsor: Centre Hospitalier Universitaire de Nīmes
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urothelial Carcinoma View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Durvalumab View
None Gemcitabine View
None Cisplatin View
None Chemotherapy View